Kindly Md, Inc. shares rise 1.60% after-hours following Cyclerion's transformational relaunch and MIT licensing agreement.

Tuesday, Sep 23, 2025 4:53 pm ET1min read
Kindly Md, Inc. rose 1.60% in after-hours trading, with Cyclerion Therapeutics, Inc. announcing a strategic relaunch and licensing agreement with MIT to advance a Phase 2-ready program for treatment-resistant depression. This news aligns with the positive movement of the stock.

Kindly Md, Inc. shares rise 1.60% after-hours following Cyclerion's transformational relaunch and MIT licensing agreement.

Comments



Add a public comment...
No comments

No comments yet